Ferring announces 30 million CHF investment in new biotech centre in Switzerland
Ferring Announces Recipients of Innovation Grants Program 2017-2018
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
Ferring and the Chinese Academy of Sciences collaborate to advance research in reproductive medicine
Ferring International Center S.A.Ch. de la Vergognausaz 50CH-1162 Saint-PrexSwitzerlandTel: +41 58 301 00 00Fax: +41 58 301 00 10
Email for media enquiries only.For other queries, please see our Contact page.
FERRING INTERNATIONAL CENTER S.A.CH. DE LA VERGOGNAUSAZ 50 1162 SAINT-PREXSWITZERLAND
TEL: +41 58 301 00 00FAX: +41 58 301 00 10
This global corporate website provides general information about the global Ferring Group. For information about Ferring or its products in a specific country, please select your country in the Global Locator. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. save where indicated otherwise. ©2017 Ferring B.V.